Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€41.20
25.03.23
-
25.03.24
-35.92%
26.03.24

William Blair 
25.03.23 50%
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€101.16
18.03.23
-
18.03.24
8.94%
19.03.24

StockNews.com 
18.03.23 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.33
13.03.23
€56.02
13.03.24
-56.77%
14.03.24

Royal Bank of Canada 
13.03.23 50%
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€102.32
11.03.23
-
11.03.24
7.90%
12.03.24

StockNews.com 
11.03.23 50%
buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
11.03.23
-
11.03.24
2.80%
12.03.24

StockNews.com 
11.03.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€19.11
17.04.23
-
17.04.27
-31.98%
11.03.24

Could be very worthwhile Investment >20% year
Lutz69 
17.04.23 50%
sell
Viatris Inc.

Start price
Target price
Perf. (%)
€9.76
18.10.22
-
18.11.26
13.97%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
sell
Viatris Inc.

Start price
Target price
Perf. (%)
€9.76
18.10.22
-
18.11.26
13.97%
11.03.24

Probably not worthwhile Investment
Lutz69 
18.10.22 50%
sell
MorphoSys AG

Start price
Target price
Perf. (%)
€16.57
05.09.22
-
05.10.26
293.97%
11.03.24

Probably not worthwhile Investment
Lutz69 
05.09.22 50%
sell
MorphoSys AG

Start price
Target price
Perf. (%)
€16.57
05.09.22
-
05.10.26
293.97%
11.03.24

Probably not worthwhile Investment
Lutz69 
05.09.22 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
08.08.22
-
08.08.26
-
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
08.08.22 50%
sell
QIAGEN NV

Start price
Target price
Perf. (%)
€40.90
07.03.22
-
07.03.25
2.08%
11.03.24

Probably not worthwhile Investment
Lutz69 
07.03.22 50%
sell
QIAGEN NV

Start price
Target price
Perf. (%)
€40.90
07.03.22
-
07.03.25
2.08%
11.03.24

Probably not worthwhile Investment
Lutz69 
07.03.22 50%
sell
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€20.20
10.03.23
-
10.03.24
38.61%
11.03.24

StockNews.com 
10.03.23 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€18.87
10.03.23
-
10.03.24
-91.41%
11.03.24

StockNews.com 
10.03.23 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€15.79
09.03.23
€21.75
09.03.24
28.09%
10.03.24

Wells Fargo & Company 
09.03.23 50%
buy
Perrigo Co. plc

Start price
Target price
Perf. (%)
€35.16
07.03.23
€45.97
07.03.24
-19.80%
08.03.24

Canaccord Genuity Group Inc. 
07.03.23 50%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€4.70
06.03.23
-
06.03.24
-72.04%
07.03.24

Robert W. Baird 
06.03.23 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.50
06.03.23
€60.06
06.03.24
-10.61%
07.03.24

Morgan Stanley 
06.03.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€136.50
06.03.23
€191.43
06.03.24
-20.88%
07.03.24

HC Wainwright 
06.03.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€137.36
03.03.23
€199.47
03.03.24
-19.63%
04.03.24

The Goldman Sachs Group, Inc. 
03.03.23 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€15.98
03.03.23
€22.62
03.03.24
26.83%
04.03.24

EF Hutton Acquisition Co. I 
03.03.23 50%
buy
Myriad Genetics

Start price
Target price
Perf. (%)
€21.85
03.03.23
€25.45
03.03.24
-7.55%
04.03.24

Raymond James 
03.03.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€189.54
03.03.23
€390.56
03.03.24
-25.40%
04.03.24

HC Wainwright 
03.03.23 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€95.10
03.03.23
-
03.03.24
26.60%
04.03.24

Evercore ISI 
03.03.23 50%